Cell & Gene Therapy Manufacturing Services Market by Type (Allogeneic, Autologous, Viral Vector, Non-viral vector), Indication (Cancer, Orthopedic), Application (Clinical, Commercial), End User (Pharma & Biotech, Academia) - Global Forecast to 2026

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS & EXCLUSIONS
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED.. 46
1.3.2              YEARS CONSIDERED IN THE REPORT
1.4             CURRENCY
1.5             LIMITATIONS
1.6             STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
・       FIGURE 1.................................................. RESEARCH DESIGN.. 49
2.1.1              SECONDARY DATA
2.1.2              PRIMARY DATA
・       FIGURE 2.................................................. PRIMARY SOURCES.. 51
・       FIGURE 3......... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
BREAKDOWN OF PRIMARIES
2.1.2.1            KEY INDUSTRY INSIGHTS
2.2             MARKET SIZE ESTIMATION
・       FIGURE 4..................... MARKET SIZE ESTIMATION: APPROACH 1 –
REVENUE SHARE ANALYSIS, 2020
・       FIGURE 5..................... AVERAGE MARKET SIZE ESTIMATION, 2020
・       FIGURE 6......... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
CAGR PROJECTIONS, 2021–2026
・       FIGURE 7......... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
2.3             MARKET BREAKDOWN AND DATA TRIANGULATION
・       FIGURE 8.......................... DATA TRIANGULATION METHODOLOGY
2.4             RESEARCH ASSUMPTIONS
2.5             RISK ANALYSIS

3.... EXECUTIVE SUMMARY

・       FIGURE 9......... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)
・       FIGURE 10....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2021 VS. 2026 (USD MILLION)
・       FIGURE 11....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2021 VS. 2026 (USD MILLION)
・       FIGURE 12....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
・       FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET

4.... PREMIUM INSIGHTS

4.1             CELL & GENE THERAPY MANUFACTURING SERVICES MARKET OVERVIEW
・       FIGURE 14.......... HIGH INCIDENCE OF CANCER AND OTHER TARGET DISEASES TO
DRIVE MARKET GROWTH
4.2             NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE & COUNTRY (2020)
・       FIGURE 15........ THE CELL THERAPY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF
THE NORTH AMERICAN MARKET IN 2020
4.3             CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SHARE,
BY APPLICATION, 2020
・       FIGURE 16.. THE CLINICAL MANUFACTURING SEGMENT DOMINATED THE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET IN 2020
4.4             CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION, 2021–2026
・       FIGURE 17.. ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 18....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・       TABLE 1........... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
IMPACT ANALYSIS
5.2.1              DRIVERS
5.2.1.1            HIGH INCIDENCE OF CANCER AND OTHER TARGET DISEASES
5.2.1.2            INCREASING INVESTMENTS IN PHARMACEUTICAL R&D
・       FIGURE 19 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2016
5.2.1.3            INVESTMENTS IN ADVANCED TECHNOLOGIES BY CDMOS
5.2.1.4            INCREASING PARTNERSHIPS AND AGREEMENTS BETWEEN PHARMACEUTICAL COMPANIES AND CDMOS
5.2.2              RESTRAINTS
5.2.2.1            HIGH OPERATIONAL COSTS ASSOCIATED WITH CELL & GENE THERAPY MANUFACTURING
5.2.3              OPPORTUNITIES
5.2.3.1            RISING DEMAND FOR CELL & GENE THERAPIES
5.2.3.2            INCREASING NUMBER OF CELL & GENE THERAPY CLINICAL TRIALS
5.2.4              CHALLENGES
5.2.4.1            RISK OF MUTAGENESIS AND OTHER UNWANTED OUTCOMES
5.2.5              TRENDS
5.2.5.1            EXPANSION IN EMERGING COUNTRIES
5.3             IMPACT OF THE COVID-19 OUTBREAK ON THE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET
・       FIGURE 20....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SCENARIO, PRE-COVID-19 VS. POST-COVID-19 IMPACT, 2019–2021
5.4             TECHNOLOGICAL ANALYSIS
5.5             CASE STUDIES
5.5.1              CGT CATAPULT PROVIDED ITS EXPERTISE IN THERAPIES DEVELOPMENT
AND MANUFACTURING TO CREATE A NEW PRECLINICAL DEVELOPMENT PLAN FOR PURESPRING THERAPEUTICS’ GENE THERAPY TECHNOLOGY FOR
KIDNEY DISEASES
5.6             RANGES/SCENARIO
・       FIGURE 21.... SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES
ON THE GROWTH OF THE CELL & GENE THERAPY MANUFACTURING
SERVICES MARKET
5.7             TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・       FIGURE 22........ REVENUE SHIFT & NEW POCKETS FOR CELL & GENE THERAPY MANUFACTURING SERVICE PROVIDERS
5.8             PRICING ANALYSIS
5.9             VALUE CHAIN ANALYSIS.. 75
・       FIGURE 23.... VALUE CHAIN ANALYSIS OF THE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: HARVESTING AND CRYOPRESERVATION PHASES ADD MAXIMUM VALUE
5.10          ECOSYSTEM ANALYSIS OF THE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET
・       FIGURE 24..... ECOSYSTEM ANALYSIS OF THE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET
・       TABLE 2.......................................... SUPPLY CHAIN ECOSYSTEM
5.11          PORTER’S FIVE FORCES ANALYSIS
・       TABLE 3........... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
PORTER’S FIVE FORCES ANALYSIS
5.11.1            THREAT FROM NEW ENTRANTS
5.11.2            THREAT FROM SUBSTITUTES
5.11.3            BARGAINING POWER OF BUYERS
5.11.4            BARGAINING POWER OF SUPPLIERS
5.11.5            INTENSITY OF COMPETITIVE RIVALRY
5.12          REGULATORY ANALYSIS.. 79
5.12.1            NORTH AMERICA
5.12.1.1          US
5.12.1.2          CANADA
5.12.2            EUROPE
5.12.2.1          GERMANY
5.12.2.2          FRANCE
5.12.2.3          UK
5.12.2.4          REST OF EUROPE
5.12.3            ASIA PACIFIC
5.12.3.1          CHINA
5.12.3.2          JAPAN
5.12.3.3          REST OF ASIA PACIFIC
5.12.3.3.1          INDIA
5.12.3.3.2          AUSTRALIA AND NEW ZEALAND
5.12.4            LATIN AMERICA
5.12.5            MIDDLE EAST & AFRICA
5.13          PATENT ANALYSIS
・       FIGURE 25.... NUMBER OF PATENT APPLICATIONS FILED FOR CELL & GENE THERAPY MANUFACTURING SERVICES, JANUARY 2010–DECEMBER 2020

6.... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE

6.1             INTRODUCTION
・       TABLE 4........... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2             CELL THERAPY
・       TABLE 5..... CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)
・       TABLE 6..... CELL THERAPY MANUFACTURING SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION)
・       TABLE 7............ NORTH AMERICA: CELL THERAPY MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 8......... EUROPE: CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 9... ASIA PACIFIC: CELL THERAPY MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1              ALLOGENEIC
・       TABLE 10... ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 11... ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
・       TABLE 12................. NORTH AMERICA: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 13.... EUROPE: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 14..................... ASIA PACIFIC: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1.1            MESENCHYMAL STEM CELLS
6.2.1.1.1            MSCS ARE IDEAL FOR CELL THERAPY BECAUSE OF THEIR IMMUNOSUPPRESSIVE AND TISSUE REPAIR PROPERTIES
・       TABLE 15 ALLOGENEIC MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 16 NORTH AMERICA: ALLOGENEIC MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 17........... EUROPE: ALLOGENEIC MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 18..... ASIA PACIFIC: ALLOGENEIC MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1.2            T-CELLS
6.2.1.2.1            ALLOGENEIC T-CELLS ARE IMMEDIATELY AVAILABLE BECAUSE OF CRYOPRESERVED BATCHES
・       TABLE 19 ALLOGENEIC T-CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 20... NORTH AMERICA: ALLOGENEIC T-CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 21............ EUROPE: ALLOGENEIC T-CELLS MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 22....... ASIA PACIFIC: ALLOGENEIC T-CELL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1.3            INDUCED PLURIPOTENT STEM CELLS
6.2.1.3.1            GROWING ADOPTION OF IPSCS IN RESEARCH TO
DRIVE MARKET GROWTH
・       TABLE 23............. ALLOGENEIC INDUCED PLURIPOTENT STEM CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 24..... NORTH AMERICA: ALLOGENEIC INDUCED PLURIPOTENT STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 25. EUROPE: ALLOGENEIC INDUCED PLURIPOTENT STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 26.. ASIA PACIFIC: ALLOGENEIC INDUCED PLURIPOTENT STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
6.2.1.4            NATURAL KILLER CELLS
6.2.1.4.1            ALLOGENEIC NATURAL KILLER CELL THERAPIES ARE USED FOR ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS
・       TABLE 27...... ALLOGENEIC NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 28....... NORTH AMERICA: ALLOGENEIC NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 29.................. EUROPE: ALLOGENEIC NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 30............ ASIA PACIFIC: ALLOGENEIC NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1.5            HEMATOPOIETIC STEM CELLS
6.2.1.5.1            STEM CELLS FROM A DONOR ARE USED FOR ALLOGENEIC TRANSPLANTATION
・       TABLE 31 ALLOGENEIC HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 32 NORTH AMERICA: ALLOGENEIC HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 33.......... EUROPE: ALLOGENEIC HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 34.... ASIA PACIFIC: ALLOGENEIC HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1.6            OTHER ALLOGENEIC CELLS
・       TABLE 35..... OTHER ALLOGENEIC CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 36.................... NORTH AMERICA: OTHER ALLOGENEIC CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 37....... EUROPE: OTHER ALLOGENEIC CELL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 38. ASIA PACIFIC: OTHER ALLOGENEIC CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2              AUTOLOGOUS
・       TABLE 39. AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 40. AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
・       TABLE 41............... NORTH AMERICA: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 42.. EUROPE: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 43.................... ASIA PACIFIC: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2.1            T-CELLS
6.2.2.1.1            T-CELLS ARE MAJOR COMPONENTS OF THE ADAPTIVE
IMMUNE SYSTEM
・       TABLE 44........... AUTOLOGOUS T-CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 45. NORTH AMERICA: AUTOLOGOUS T-CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 46 EUROPE: AUTOLOGOUS T-CELL MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 47...... ASIA PACIFIC: AUTOLOGOUS T-CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2.2            HEMATOPOIETIC STEM CELLS
6.2.2.2.1            HEMATOPOIETIC STEM CELLS ARE USED TO ESTABLISH MARROW
AND BONE FUNCTION
・       TABLE 48..................... AUTOLOGOUS HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 49..... NORTH AMERICA: AUTOLOGOUS HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 50......... EUROPE: AUTOLOGOUS HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 51.. ASIA PACIFIC: AUTOLOGOUS HEMATOPOIETIC STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2.3            MESENCHYMAL STEM CELLS
6.2.2.3.1            MESENCHYMAL STEM CELLS ARE PRESENT IN THE UMBILICAL
CORD, BONE MARROW, & FAT TISSUE
・       TABLE 52...................... AUTOLOGOUS MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 53..... NORTH AMERICA: AUTOLOGOUS MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 54.......... EUROPE: AUTOLOGOUS MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 55... ASIA PACIFIC: AUTOLOGOUS MESENCHYMAL STEM CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2.4            NATURAL KILLER CELLS
6.2.2.4.1            NK CELLS ARE USED IN THE TREATMENT OF TUMORS AND
INFECTIOUS DISEASES
・       TABLE 56..... AUTOLOGOUS NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 57..... NORTH AMERICA: AUTOLOGOUS NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 58................. EUROPE: AUTOLOGOUS NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 59.......... ASIA PACIFIC: AUTOLOGOUS NATURAL KILLER CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2.5            OTHER AUTOLOGOUS CELLS
・       TABLE 60.... OTHER AUTOLOGOUS CELL MANUFACTURING SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
・       TABLE 61.................. NORTH AMERICA: OTHER AUTOLOGOUS CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 62..... EUROPE: OTHER AUTOLOGOUS CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 63 ASIA PACIFIC: OTHER AUTOLOGOUS CELL MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3              VIRAL VECTOR
・       TABLE 64. VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 65. VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
・       TABLE 66............... NORTH AMERICA: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 67.. EUROPE: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 68................... ASIA PACIFIC: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3.1            RETROVIRAL VECTORS
6.2.3.1.1            RETROVIRAL VECTORS ARE THE MOST USED VIRAL VECTORS FOR CELL THERAPY MANUFACTURING
・       TABLE 69...... RETROVIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 70...... NORTH AMERICA: RETROVIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 71................. EUROPE: RETROVIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 72........... ASIA PACIFIC: RETROVIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3.2            ADENO-ASSOCIATED VIRUS VECTORS
6.2.3.2.1            AAV VECTOR-BASED TECHNIQUES ARE USED FOR CAR-T CELL
THERAPY DEVELOPMENT
・       TABLE 73.......... ADENO-ASSOCIATED VIRUS VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 74 NORTH AMERICA: ADENO-ASSOCIATED VIRUS VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 75.......... EUROPE: ADENO-ASSOCIATED VIRUS VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 76.... ASIA PACIFIC: ADENO-ASSOCIATED VIRUS VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
6.2.3.3            OTHER VIRAL VECTORS
・       TABLE 77..... OTHER VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 78..... NORTH AMERICA: OTHER VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 79................. EUROPE: OTHER VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 80.......... ASIA PACIFIC: OTHER VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3             GENE THERAPY
・       TABLE 81... GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR,
2019–2026 (USD MILLION)
・       TABLE 82... GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION)
・       TABLE 83......... NORTH AMERICA: GENE THERAPY MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 84....... EUROPE: GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 85 ASIA PACIFIC: GENE THERAPY MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1              NON-VIRAL VECTORS.. 118
・       TABLE 86...... NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 87...... NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
・       TABLE 88....... NORTH AMERICA: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 89.................. EUROPE: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 90............ ASIA PACIFIC: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1.1            OLIGONUCLEOTIDES
6.3.1.1.1            NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE OLIGONUCLEOTIDES MARKET
・       TABLE 91. OLIGONUCLEOTIDE MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 92.... NORTH AMERICA: OLIGONUCLEOTIDE MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 93. EUROPE: OLIGONUCLEOTIDE MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 94......... ASIA PACIFIC: OLIGONUCLEOTIDE MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1.2            OTHER NON-VIRAL VECTORS
・       TABLE 95.... OTHER NON-VIRAL VECTOR MANUFACTURING SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
・       TABLE 96.................. NORTH AMERICA: OTHER NON-VIRAL VECTOR MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 97..... EUROPE: OTHER NON-VIRAL VECTOR MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 98 ASIA PACIFIC: OTHER NON-VIRAL VECTOR MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2              VIRAL VECTORS
・       TABLE 99 VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 100............ VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
・       TABLE 101............ NORTH AMERICA: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 102 EUROPE: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 103................. ASIA PACIFIC: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2.1            RETROVIRAL VECTORS
6.3.2.1.1            RETROVIRAL VECTORS POSSESS THE ABILITY TO REPLICATE
WITHIN A CELL
・       TABLE 104... RETROVIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 105... NORTH AMERICA: RETROVIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 106.............. EUROPE: RETROVIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 107........ ASIA PACIFIC: RETROVIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2.2            ADENO-ASSOCIATED VIRUS VECTORS
6.3.2.2.1            ADENO-ASSOCIATED VIRUS VECTORS HAVE LOW TOXICITY
・       TABLE 108....... ADENO-ASSOCIATED VIRUS VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 109.... NORTH AMERICA: ADENO-ASSOCIATED VIRUS VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 110....... EUROPE: ADENO-ASSOCIATED VIRUS VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 111. ASIA PACIFIC: ADENO-ASSOCIATED VIRUS VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION)
6.3.2.3            OTHER VIRAL VECTORS
・       TABLE 112.. OTHER VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 113... NORTH AMERICA: OTHER VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 114.............. EUROPE: OTHER VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 115....... ASIA PACIFIC: OTHER VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7.... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY INDICATION

7.1             INTRODUCTION
・       TABLE 116....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
7.2             ONCOLOGY DISEASES
7.2.1              THE DEMAND FOR CELL & GENE THERAPIES IS INCREASING WITH THE RISING NUMBER OF CANCER CASES WORLDWIDE
・       TABLE 117....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ONCOLOGY DISEASES, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 118..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ONCOLOGY DISEASES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 119......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ONCOLOGY DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 120.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ONCOLOGY DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
7.3             CARDIOVASCULAR DISEASES
7.3.1              GROWING INCIDENCE OF CARDIOVASCULAR DISEASES OWING TO SEDENTARY LIFESTYLES DRIVES THE MARKET GROWTH
・       TABLE 121....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 122..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 123......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 124.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY,
2019–2026 (USD MILLION)
7.4             ORTHOPEDIC DISEASES
7.4.1              CELL THERAPY FOR ORTHOPEDIC DISEASES ELIMINATES
POST-TREATMENT COMPLICATIONS
・       TABLE 125....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ORTHOPEDIC DISEASES, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 126..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ORTHOPEDIC DISEASES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 127......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ORTHOPEDIC DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 128.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ORTHOPEDIC DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
7.5             OPTHALMOLOGY DISEASES
7.5.1              STEM CELL THERAPIES CAN BE USED FOR THE RESTORATION & PRESERVATION OF VISION; KEY FACTOR DRIVING MARKET GROWTH
・       TABLE 129....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OPTHALMOLOGY DISEASES, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 130..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OPTHALMOLOGY DISEASES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 131......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OPTHALMOLOGY DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 132.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OPTHALMOLOGY DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
7.6             CENTRAL NERVOUS SYSTEM DISORDERS
7.6.1              INCREASING INCIDENCE OF SPINAL MUSCULAR ATROPHY SUPPORTS
THE MARKET GROWTH
・       TABLE 133....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 134..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 135......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 136.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY,
2019–2026 (USD MILLION)
7.7             INFECTIOUS DISEASES
7.7.1              THE INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE
THE MARKET GROWTH OF THIS SEGMENT
・       TABLE 137....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 138..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 139......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 140.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
7.8             OTHER INDICATIONS
・       TABLE 141....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER INDICATIONS, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 142..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 143......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 144.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

8.... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION

8.1             INTRODUCTION
・       TABLE 145....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
8.2             CLINICAL MANUFACTURING
8.2.1              THE RISING NUMBER OF CLINICAL TRIALS FOR CELL & GENE THERAPIES IS EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT
・       TABLE 146....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CLINICAL MANUFACTURING, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 147..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CLINICAL MANUFACTURING, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 148......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CLINICAL MANUFACTURING, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 149.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR CLINICAL MANUFACTURING, BY COUNTRY, 2019–2026 (USD MILLION)
8.3             COMMERCIAL MANUFACTURING
8.3.1              MARKET GROWTH CAN BE ATTRIBUTED TO THE INCREASING APPROVALS OF CELL & GENE THERAPY PRODUCTS FOR COMMERCIAL MANUFACTURING
・       TABLE 150....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR COMMERCIAL MANUFACTURING, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 151..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR COMMERCIAL MANUFACTURING, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 152......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR COMMERCIAL MANUFACTURING, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 153.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR COMMERCIAL MANUFACTURING, BY COUNTRY,
2019–2026 (USD MILLION)

9.... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY END USER

9.1             INTRODUCTION
・       TABLE 154....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2             PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1              GROWING NUMBER OF CELL & GENE THERAPIES IN THE R&D PIPELINE TO DRIVE THE MARKET GROWTH
・       TABLE 155....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION,
2019–2026 (USD MILLION)
・       TABLE 156..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 157......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 158.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
9.3             ACADEMIC & RESEARCH INSTITUTES
9.3.1              INCREASE IN LIFE SCIENCES R&D EXPENDITURE TO CONTRIBUTE TO THE GROWTH OF THIS SEGMENT. 153
・       TABLE 159....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 160..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 161......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION)
・       TABLE 162.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,
2019–2026 (USD MILLION)
9.4             OTHER END USERS
・       TABLE 163....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
・       TABLE 164..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 165......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 166.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

10.. CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION

10.1          INTRODUCTION
・       TABLE 167......... CELL & GENE THERAPY MANUFACTURING THERAPY SERVICES MARKET,
BY REGION, 2019–2026 (USD MILLION)
10.2          NORTH AMERICA
・       FIGURE 26..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SNAPSHOT
・       TABLE 168..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 169..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 170........ NORTH AMERICA: CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 171............... NORTH AMERICA: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 172............. NORTH AMERICA: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 173............. NORTH AMERICA: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 174....... NORTH AMERICA: GENE THERAPY MANUFACTURING SERVICES MARKET,
BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 175..... NORTH AMERICA: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 176............ NORTH AMERICA: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 177..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 178..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 179..................... NORTH AMERICA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1            US
10.2.1.1          GROWING FOCUS ON CANCER RESEARCH IN THE US WILL DRIVE MARKET GROWTH
・       TABLE 180.. US: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 181 US: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)
・       TABLE 182......... US: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 183........ US: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 184....... US: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 185 US: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 186 US: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 187...... US: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 188.. US: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 189.. US: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 190.. US: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.2.2            CANADA
10.2.2.1          GROWTH IN CANADA CAN BE ATTRIBUTED TO THE RISING FUNDING FOR STEM CELL RESEARCH IN THE COUNTRY
・       TABLE 191........ CANADA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 192..... CANADA: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 193.. CANADA: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 194 CANADA: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 195 CANADA: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 196.... CANADA: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 197................ CANADA: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 198 CANADA: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 199........ CANADA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 200........ CANADA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 201........ CANADA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.3          EUROPE
・       TABLE 202......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 203......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 204...... EUROPE: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 205.. EUROPE: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 206. EUROPE: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 207 EUROPE: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 208..... EUROPE: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 209................ EUROPE: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 210 EUROPE: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 211......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 212......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 213......... EUROPE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.3.1            GERMANY
10.3.1.1          GOVERNMENT FUNDING FOR LIFE SCIENCE R&D AND BASIC CANCER RESEARCH WILL DRIVE MARKET GROWTH
・       TABLE 214...... GERMANY: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 215... GERMANY: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 216 GERMANY: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 217...................... GERMANY: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 218...................... GERMANY: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 219.. GERMANY: GENE THERAPY MANUFACTURING SERVICES MARKET,
BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 220.............. GERMANY: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 221..................... GERMANY: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 222...... GERMANY: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 223...... GERMANY: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 224...... GERMANY: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.3.2            UK
10.3.2.1          THE RISING INCIDENCE OF CANCER CASES WILL LEAD TO AN INCREASE IN CANCER RESEARCH, WHICH WILL DRIVE MARKET GROWTH
・       TABLE 225.. UK: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 226 UK: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)
・       TABLE 227......... UK: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 228........ UK: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 229....... UK: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 230 UK: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 231 UK: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 232...... UK: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 233.. UK: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 234.. UK: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 235.. UK: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.3.3            FRANCE
10.3.3.1          GROWTH CAN BE ATTRIBUTED TO RISING GOVERNMENT FUNDING FOR
CANCER RESEARCH
・       TABLE 236......... FRANCE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 237...... FRANCE: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 238.. FRANCE: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 239. FRANCE: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 240 FRANCE: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 241..... FRANCE: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 242................ FRANCE: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 243 FRANCE: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 244......... FRANCE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 245......... FRANCE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 246......... FRANCE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.3.4            REST OF EUROPE
・       TABLE 247 ROE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 248........... ROE: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)
・       TABLE 249....... ROE: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 250...... ROE: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 251..... ROE: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 252.......... ROE: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 253...................... ROE: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 254..... ROE: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 255 ROE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 256 ROE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 257 ROE: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.4          ASIA PACIFIC
・       FIGURE 27.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING
SERVICES MARKET SNAPSHOT
・       TABLE 258.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
・       TABLE 259.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 260 ASIA PACIFIC: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 261.................... ASIA PACIFIC: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 262.................. ASIA PACIFIC: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 263.................. ASIA PACIFIC: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 264............ ASIA PACIFIC: GENE THERAPY MANUFACTURING SERVICES MARKET,
BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 265.......... ASIA PACIFIC: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 266................. ASIA PACIFIC: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 267.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY INDICATION, 2019–2026 (USD MILLION). 197
・       TABLE 268.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION). 197
・       TABLE 269.. ASIA PACIFIC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1            CHINA
10.4.1.1          THE GROWING PHARMACEUTICAL INDUSTRY AND RISING NUMBER OF CDMOS IN THE COUNTRY WILL DRIVE MARKET GROWTH
・       TABLE 270........... CHINA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 271........ CHINA: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 272..... CHINA: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 273... CHINA: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 274... CHINA: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 275....... CHINA: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 276................... CHINA: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 277.. CHINA: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 278........... CHINA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 279........... CHINA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 280........... CHINA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.4.2            JAPAN
10.4.2.1          RESEARCH COLLABORATIONS AND GROWING GERIATRIC POPULATION—
KEY GROWTH DRIVERS IN JAPAN
・       TABLE 281........... JAPAN: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 282........ JAPAN: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 283..... JAPAN: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 284... JAPAN: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 285... JAPAN: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 286....... JAPAN: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 287................... JAPAN: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 288.. JAPAN: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 289........... JAPAN: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 290........... JAPAN: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 291........... JAPAN: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.4.3            REST OF ASIA PACIFIC
・       TABLE 292........ ROAPAC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 293..... ROAPAC: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 294.. ROAPAC: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 295 ROAPAC: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 296 ROAPAC: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 297..... ROAPAC: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 298................ ROAPAC: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 299 ROAPAC: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 300........ ROAPAC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 301........ ROAPAC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 302........ ROAPAC: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.5          LATIN AMERICA
10.5.1            RISING PHARMACEUTICAL R&D EXPENDITURE IN THE REGION WILL DRIVE THE GROWTH OF THE MARKET
・       TABLE 303........... LATAM: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 304........ LATAM: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 305.... LATAM: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 306... LATAM: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 307.. LATAM: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 308....... LATAM: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 309.................. LATAM: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 310. LATAM: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 311........... LATAM: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 312........... LATAM: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 313........... LATAM: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)
10.6          MIDDLE EAST & AFRICA
10.6.1            MARKET GROWTH DRIVEN BY CHANGING DEMOGRAPHICS AND FAVORABLE POLICIES FOR PHARMA R&D.. 215
・       TABLE 314 MEA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 315.......... MEA: CELL THERAPY MANUFACTURING SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION)
・       TABLE 316....... MEA: ALLOGENEIC CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 317..... MEA: AUTOLOGOUS CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 318..... MEA: VIRAL VECTOR CELL THERAPY MANUFACTURING SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 319.......... MEA: GENE THERAPY MANUFACTURING SERVICES MARKET, BY VECTOR, 2019–2026 (USD MILLION)
・       TABLE 320..................... MEA: NON-VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 321.... MEA: VIRAL VECTOR GENE THERAPY MANUFACTURING SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
・       TABLE 322 MEA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY INDICATION, 2019–2026 (USD MILLION)
・       TABLE 323 MEA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION)
・       TABLE 324 MEA: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET,
BY END USER, 2019–2026 (USD MILLION)

11.. COMPETITIVE LANDSCAPE

11.1          OVERVIEW
11.2          KEY PLAYER STRATEGIES/RIGHT TO WIN
・       FIGURE 28... KEY PLAYER STRATEGIES IN THE CELL & GENE THERAPY MANUFACTURING SERVICES MARKET, 2018–2021
11.3          MARKET SHARE ANALYSIS
・       FIGURE 29....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
11.4          REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・       FIGURE 30..... REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
11.5          COMPANY EVALUATION QUADRANT
11.5.1            STARS
11.5.2            EMERGING LEADERS
11.5.3            PERVASIVE PLAYERS
11.5.4            EMERGING COMPANIES
・       FIGURE 31....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET: COMPANY EVALUATION QUADRANT, 2020
11.6          COMPANY EVALUATION QUADRANT: START-UPS/SMES
11.6.1            PROGRESSIVE COMPANIES
11.6.2            STARTING BLOCKS
11.6.3            RESPONSIVE COMPANIES
11.6.4            DYNAMIC COMPANIES
・       FIGURE 32....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
11.7          SERVICE FOOTPRINT OF COMPANIES
・       TABLE 325... SERVICE PORTFOLIO ANALYSIS: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET (2020)
11.8          REGIONAL FOOTPRINT OF COMPANIES
・       TABLE 326...... REGIONAL FOOTPRINT OF COMPANIES: CELL & GENE THERAPY MANUFACTURING SERVICES MARKET (2020) 229
11.9          COMPETITIVE SCENARIO
・       TABLE 327....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
DEALS, JANUARY 2018–JUNE 2021
・       TABLE 328....... CELL & GENE THERAPY MANUFACTURING SERVICES MARKET:
OTHER DEVELOPMENTS, JANUARY 2018 –JUNE 2021

12.. COMPANY PROFILES

12.1          KEY MARKET PLAYERS
(BUSINESS OVERVIEW, SERVICES OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW)*
12.1.1            THERMO FISHER SCIENTIFIC, INC.
・       TABLE 329. THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
・       FIGURE 33. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
12.1.2            MERCK KGAA
・       TABLE 330........................... MERCK KGAA: BUSINESS OVERVIEW
・       FIGURE 34................. MERCK KGAA: COMPANY SNAPSHOT (2020)
12.1.3            CHARLES RIVER LABORATORIES
・       TABLE 331... CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
・       FIGURE 35... CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2020)
12.1.4            LONZA
・       TABLE 332.................................... LONZA: BUSINESS OVERVIEW
・       FIGURE 36.......................... LONZA: COMPANY SNAPSHOT (2020)
12.1.5            CATALENT, INC.
・       TABLE 333......................... CATALENT, INC.: BUSINESS OVERVIEW
・       FIGURE 37.............. CATALENT, INC.: COMPANY SNAPSHOT (2020)
12.1.6            TAKARA BIO INC. 257
・       TABLE 334....................... TAKARA BIO INC.: BUSINESS OVERVIEW
・       FIGURE 38............. TAKARA BIO INC.: COMPANY SNAPSHOT (2020)
12.1.7            OXFORD BIOMEDICA PLC
・       TABLE 335............ OXFORD BIOMEDICA PLC: BUSINESS OVERVIEW
・       FIGURE 39.. OXFORD BIOMEDICA PLC: COMPANY SNAPSHOT (2020)
12.1.8            CELL AND GENE THERAPY CATAPULT
・       TABLE 336............ CELL AND GENE THERAPY CATAPULT: BUSINESS OVERVIEW
・       FIGURE 40............ CELL AND GENE THERAPY CATAPULT: COMPANY SNAPSHOT (2020)
12.1.9            F. HOFFMANN-LA ROCHE LTD.
・       TABLE 337...... F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
・       FIGURE 41...... F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
12.1.10         FUJIFILM HOLDINGS CORPORATION
・       TABLE 338 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
・       FIGURE 42............. FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
12.1.11         WUXI APPTEC
・       TABLE 339........................... WUXI APPTEC: BUSINESS OVERVIEW
・       FIGURE 43................. WUXI APPTEC: COMPANY SNAPSHOT (2020)
12.1.12         NIKON CORPORATION
・       TABLE 340................ NIKON CORPORATION: BUSINESS OVERVIEW
・       FIGURE 44...... NIKON CORPORATION: COMPANY SNAPSHOT (2020)
12.2          OTHER PLAYERS
12.2.1            THE DISCOVERY LABS LLC
・       TABLE 341........... THE DISCOVERY LABS LLC: BUSINESS OVERVIEW
12.2.2            ROSLINCT
・       TABLE 342................................ ROSLINCT: BUSINESS OVERVIEW
12.2.3            JRS PHARMA
・       TABLE 343............................ JRS PHARMA: BUSINESS OVERVIEW
12.2.4            FINVECTOR
・       TABLE 344.............................. FINVECTOR: BUSINESS OVERVIEW
12.2.5            ABL, INC.
・       TABLE 345................................. ABL, INC.: BUSINESS OVERVIEW
12.2.6            RESILIENCE, INC. 283
・       TABLE 346...................... RESILIENCE, INC.: BUSINESS OVERVIEW
12.2.7            BIOCENTRIQ
・       TABLE 347............................ BIOCENTRIQ: BUSINESS OVERVIEW
12.2.8            PORTON BIOPHARMA LIMITED
・       TABLE 348...... PORTON BIOPHARMA LIMITED: BUSINESS OVERVIEW
12.2.9            ANDELYN BIOSCIENCES
12.2.10         COMMERCIALIZING LIVING THERAPIES
12.2.11         VIBALOGICS
12.2.12         ANEMOCYTE SRL
12.2.13         ELEVATE BIO
* BUSINESS OVERVIEW, SERVICES OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

13.. APPENDIX

当レポートのプレスリリースは発行されておりません。